Table 3.

The results for KEGG analysis in stable CAD patients compared to healthy subjects

Gene set	Description	Size	Leading edge number	ES	NES	P value	FDR
hsa04621	NOD-like receptor signaling pathway	8	6	− 0.77061	− 2.0947	0.0014245	0.0039551
hsa04060	Cytokine-cytokine receptor interaction	7	4	− 0.77594	− 1.9948	0.001462	0.0050427
hsa05132	Salmonella infection	5	4	− 0.87092	− 2.0026	0	0.0051911
hsa04657	IL-17 signaling pathway	7	6	− 0.8278	− 2.1093	0	0.0051911
hsa04010	MAPK signaling pathway	7	6	− 0.7715	− 1.9341	0.0014451	0.006427
hsa04151	PI3K-Akt signaling pathway	7	5	− 0.71874	− 1.855	0.005571	0.0084046
hsa05167	Kaposi sarcoma-associated herpesvirus infection	7	4	− 0.72723	− 1.8713	0.0028011	0.0085282
hsa04064	NF-kappa B signaling pathway	8	6	− 0.79671	− 2.1169	0.0013966	0.008899
hsa04668	TNF signaling pathway	9	8	− 0.67798	− 1.8731	0.002751	0.0097465
hsa05163	Human cytomegalovirus infection	5	3	− 0.77931	− 1.7897	0.004644	0.017353
hsa04620	Toll-like receptor signaling pathway	5	3	− 0.74322	− 1.7044	0.01682	0.028378
hsa05142	Chagas disease (American trypanosomiasis)	5	3	− 0.74322	− 1.7044	0.01682	0.028378
hsa05200	Pathways in cancer	7	6	− 0.6674	− 1.7301	0.011561	0.029528
hsa04932	Non-alcoholic fatty liver disease (NAFLD)	5	4	− 0.74563	− 1.7086	0.006006	0.032059
hsa04625	C-type lectin receptor signaling pathway	5	3	− 0.74881	− 1.7165	0.010753	0.032259
hsa04380	Osteoclast differentiation	7	7	− 0.65041	− 1.6467	0.016129	0.04088

KEGG, Kyoto encyclopedia of genes and genomes; CAD, coronary artery disease; FDR, false discovery rate